Shoulder Innovations Inc (
NYSE:SI -
Get Free Report) major shareholder Healthcare Holding B.V. Gilde purchased 100,000 shares of the firm's stock in a transaction on Friday, August 1st. The shares were acquired at an average price of $15.00 per share, with a total value of $1,500,000.00. Following the purchase, the insider directly owned 2,380,482 shares in the company, valued at $35,707,230. This represents a 4.39% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through
the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
Shoulder Innovations Stock Performance
SI stock traded down $0.21 during midday trading on Tuesday, reaching $14.06. 305,834 shares of the company's stock traded hands, compared to its average volume of 348,411. The firm has a market capitalization of $445.13 million, a PE ratio of -0.47 and a beta of 2.23. The company has a current ratio of 0.25, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54. Shoulder Innovations Inc has a 52 week low of $13.05 and a 52 week high of $17.94.
Shoulder Innovations Company Profile
(
Get Free Report)
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Shoulder Innov, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shoulder Innov wasn't on the list.
While Shoulder Innov currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.